Electrocardiographic Changes After Granisetron Administration for Chemotherapy Induced Nausea and Vomiting

Autor: Alidoosti Asadolah, Taslimi Farnaz, Yavari Parvin, Ameri Ahmad, Sheibani Khosro Majir, Miri Reza

Publikováno v: Acta Medica Iranica, Vol 47, Iss 4, Pp 289-292 (2009)

Cancer patient receive various cytotoxic drugs in association with antiemetic drugs such as 5HT3 receptor antagonists as their chemotherapy regimen. 5HT3 receptor antagonists have been reported to produce changes in ECG parameter. There are only a fe

Externí odkaz: https://doaj.org/article/120398df7d574ad591e85cbe2f041a24

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Treatment of an Unresectable Cutaneous Squamous Cell Carcinoma With ED&C and 5-FU.

Autor: Azin M; Drs. Azin, Ameri, Nazarian, Cusack, Asgari, and Demehri are from Massachusetts General Hospital and Harvard Medical School, Boston. Drs. Azin, Ameri, Asgari, and Demehri are from the Department of Dermatology; Dr. Nazarian is from the Department of Pathology; and Dr. Cusack is from the Department of Surgical Oncology. Dr. Tsiaris is from the Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston. Drs. Azin, Ameri, and Demehri also are from the Center for Cancer Immunology, Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School., Ameri AH; Drs. Azin, Ameri, Nazarian, Cusack, Asgari, and Demehri are from Massachusetts General Hospital and Harvard Medical School, Boston. Drs. Azin, Ameri, Asgari, and Demehri are from the Department of Dermatology; Dr. Nazarian is from the Department of Pathology; and Dr. Cusack is from the Department of Surgical Oncology. Dr. Tsiaris is from the Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston. Drs. Azin, Ameri, and Demehri also are from the Center for Cancer Immunology, Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School., Nazarian RM; Drs. Azin, Ameri, Nazarian, Cusack, Asgari, and Demehri are from Massachusetts General Hospital and Harvard Medical School, Boston. Drs. Azin, Ameri, Asgari, and Demehri are from the Department of Dermatology; Dr. Nazarian is from the Department of Pathology; and Dr. Cusack is from the Department of Surgical Oncology. Dr. Tsiaris is from the Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston. Drs. Azin, Ameri, and Demehri also are from the Center for Cancer Immunology, Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School., Cusack JC; Drs. Azin, Ameri, Nazarian, Cusack, Asgari, and Demehri are from Massachusetts General Hospital and Harvard Medical School, Boston. Drs. Azin, Ameri, Asgari, and Demehri are from the Department of Dermatology; Dr. Nazarian is from the Department of Pathology; and Dr. Cusack is from the Department of Surgical Oncology. Dr. Tsiaris is from the Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston. Drs. Azin, Ameri, and Demehri also are from the Center for Cancer Immunology, Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School., Tsiaras WG; Drs. Azin, Ameri, Nazarian, Cusack, Asgari, and Demehri are from Massachusetts General Hospital and Harvard Medical School, Boston. Drs. Azin, Ameri, Asgari, and Demehri are from the Department of Dermatology; Dr. Nazarian is from the Department of Pathology; and Dr. Cusack is from the Department of Surgical Oncology. Dr. Tsiaris is from the Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston. Drs. Azin, Ameri, and Demehri also are from the Center for Cancer Immunology, Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School., Asgari MM; Drs. Azin, Ameri, Nazarian, Cusack, Asgari, and Demehri are from Massachusetts General Hospital and Harvard Medical School, Boston. Drs. Azin, Ameri, Asgari, and Demehri are from the Department of Dermatology; Dr. Nazarian is from the Department of Pathology; and Dr. Cusack is from the Department of Surgical Oncology. Dr. Tsiaris is from the Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston. Drs. Azin, Ameri, and Demehri also are from the Center for Cancer Immunology, Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School., Demehri S; Drs. Azin, Ameri, Nazarian, Cusack, Asgari, and Demehri are from Massachusetts General Hospital and Harvard Medical School, Boston. Drs. Azin, Ameri, Asgari, and Demehri are from the Department of Dermatology; Dr. Nazarian is from the Department of Pathology; and Dr. Cusack is from the Department of Surgical Oncology. Dr. Tsiaris is from the Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston. Drs. Azin, Ameri, and Demehri also are from the Center for Cancer Immunology, Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School.

Publikováno v: Cutis [Cutis] 2023 Jul; Vol. 112 (1), pp. E27-E29.

Lethal Dermal Sarcoma in Immunosuppressed Patients.

Autor: Azin M; Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Center for Cancer Immunology, Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Ameri AH; Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Center for Cancer Immunology, Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Foreman RK; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Neel VA; Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Lorenzo ME; Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Demehri S; Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Center for Cancer Immunology, Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Publikováno v: The oncologist [Oncologist] 2022 Sep 02; Vol. 27 (9), pp. e759-e761.

Hypertrophic Lichen Planus with Histological Features of Squamous Cell Carcinoma Associated with Immune Checkpoint Blockade Therapy.

Autor: Ameri AH; Osler Medical Housestaff Training Program, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.; Center for Cancer Immunology and Cutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Foreman RK; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Vedak P; Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Chen S; Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Miller DM; Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Demehri S; Center for Cancer Immunology and Cutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Publikováno v: The oncologist [Oncologist] 2020 May; Vol. 25 (5), pp. 366-368. Date of Electronic Publication: 2020 Feb 19.